The survival of leukemia patients is related to their disease type, risk stratification, treatment, physical fitness, and degree of disease progression, and cannot be generalized.
Leukemias include acute leukemias as well as chronic leukemias. In the case of chronic myeloid leukemia, which is one of the more common types of chronic leukemia, targeted drug therapy for this type of leukemia is effective, and the vast majority of patients can achieve clinical cure and long-term survival. If the patient is suffering from acute leukemia, the condition is more aggressive and without special treatment, the average survival of the patient is only about 3 months, where infection and intracranial hemorrhage are important causes of death in acute leukemia. Therefore, patients should be treated promptly after diagnosis.
In addition, with the advances in medical technology in recent years, including clinical advances in chemotherapy, targeted therapy, hematopoietic stem cell transplantation, immunotherapy, cell therapy and other means, the prognosis of leukemia patients has greatly improved, and a considerable number of patients can obtain long-term survival, do not give up treatment.